These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 21761013)
1. Is bone scintigraphy necessary in initial staging of prostate cancer patients? Jaukovic L; Adjinovic B; Cerovic S; Joksimovic M; Soldatovic Z Hell J Nucl Med; 2011; 14(2):126-30. PubMed ID: 21761013 [TBL] [Abstract][Full Text] [Related]
2. Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer. Moslehi M; Cheki M; Salehi-Marzijarani M; Amuchastegui T; Gholamrezanezhad A Rev Esp Med Nucl Imagen Mol; 2013; 32(5):286-9. PubMed ID: 23478119 [TBL] [Abstract][Full Text] [Related]
3. When to perform bone scintigraphy in patients with newly diagnosed prostate cancer? a retrospective study. Lin Y; Mao Q; Chen B; Wang L; Liu B; Zheng X; Xie L BMC Urol; 2017 Jun; 17(1):41. PubMed ID: 28606069 [TBL] [Abstract][Full Text] [Related]
4. When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool. Briganti A; Passoni N; Ferrari M; Capitanio U; Suardi N; Gallina A; Da Pozzo LF; Picchio M; Di Girolamo V; Salonia A; Gianolli L; Messa C; Rigatti P; Montorsi F Eur Urol; 2010 Apr; 57(4):551-8. PubMed ID: 20034730 [TBL] [Abstract][Full Text] [Related]
5. [Predictive value of prostate-specific antigen and Gleason sum for results of radionuclide bone scintigraphy in patients with prostate cancer]. Wang TY; Chen XP; Li XS; Jia Yx; Cheng J; Zhang JH; Cai L; Zhang Z; Gong K; He ZS; Zhou LQ Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 44(4):528-34. PubMed ID: 22898839 [TBL] [Abstract][Full Text] [Related]
6. Bone scan can be spared in asymptomatic prostate cancer patients with PSA of <=20 ng/ml and Gleason score of <=6 at the initial stage of diagnosis. Tanaka N; Fujimoto K; Shinkai T; Nakai Y; Kuwada M; Anai S; Miyake M; Hirayama A; Hasegawa M; Hirao Y Jpn J Clin Oncol; 2011 Oct; 41(10):1209-13. PubMed ID: 21862505 [TBL] [Abstract][Full Text] [Related]
7. [A comparaison between the total PSA, the Gleason score and the bone scintiscan results for different age groups]. Rusu D; Rusu V; Stefănescu C; Rusu M; Răileanu I; Stătescu AM Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):476-83. PubMed ID: 20700990 [TBL] [Abstract][Full Text] [Related]
8. Influence of local tumour stage and grade on reliability of serum prostate-specific antigen in predicting skeletal metastases in patients with adenocarcinoma of the prostate. Bruwer G; Heyns CF; Allen FJ Eur Urol; 1999; 35(3):223-7. PubMed ID: 10072624 [TBL] [Abstract][Full Text] [Related]
9. When is a bone scan study appropriate in asymptomatic men diagnosed with prostate cancer? Pal RP; Thiruudaian T; Khan MA Asian J Androl; 2008 Nov; 10(6):890-5. PubMed ID: 18958353 [TBL] [Abstract][Full Text] [Related]
10. Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? A multicenter retrospective study in Japan. Kosuda S; Yoshimura I; Aizawa T; Koizumi K; Akakura K; Kuyama J; Ichihara K; Yonese J; Koizumi M; Nakashima J; Fujii H Cancer; 2002 Feb; 94(4):964-72. PubMed ID: 11920464 [TBL] [Abstract][Full Text] [Related]
11. Predicting bone scan findings using sPSA in patients newly diagnosed of prostate cancer: feasibility in Asian population. Lai MH; Luk WH; Chan JC Urol Oncol; 2011; 29(3):275-9. PubMed ID: 19734069 [TBL] [Abstract][Full Text] [Related]
12. Prostate cancer in patients from rural and suburban areas--PSA value, Gleason score and presence of metastases in bone scan. Szot W; Kostkiewicz M; Zając J; Owoc A; Bojar I Ann Agric Environ Med; 2014; 21(4):888-92. PubMed ID: 25528940 [TBL] [Abstract][Full Text] [Related]
13. Can prostate-specific antigen levels predict bone scan evidence of metastases in newly diagnosed prostate cancer? Vijayakumar V; Vijayakumar S; Quadri SF; Blend MJ Am J Clin Oncol; 1994 Oct; 17(5):432-6. PubMed ID: 7522394 [TBL] [Abstract][Full Text] [Related]
14. Serum prostate-specific antigen as a predictor of radiographic staging studies in newly diagnosed prostate cancer. Huncharek M; Muscat J Cancer Invest; 1995; 13(1):31-5. PubMed ID: 7530590 [TBL] [Abstract][Full Text] [Related]
15. Using prostate-specific antigen to eliminate the staging radionuclide bone scan. Lee CT; Oesterling JE Urol Clin North Am; 1997 May; 24(2):389-94. PubMed ID: 9126236 [TBL] [Abstract][Full Text] [Related]
16. Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters. Chybowski FM; Keller JJ; Bergstralh EJ; Oesterling JE J Urol; 1991 Feb; 145(2):313-8. PubMed ID: 1703240 [TBL] [Abstract][Full Text] [Related]
17. The relationship between the serum prostate specific antigen and whole body scintigraphy in prostate cancer patients after prostatectomy. Begic A; Kucukalic-Selimovic E; Obralic N; Duric O; Lacevic N; Begovic-Hadzimuratovic S; Skopljak A; Dzubur-Aganovic M Med Arh; 2006; 60(1):54-5. PubMed ID: 16425536 [TBL] [Abstract][Full Text] [Related]
18. Metastasis on bone scan with low prostate specific antigen (≤20 ng/ml) and Gleason's score (<8) in newly diagnosed Pakistani males with prostate cancer: should we follow Western guidelines? Zaman MU; Fatima N; Sajjad Z Asian Pac J Cancer Prev; 2011; 12(6):1529-32. PubMed ID: 22126493 [TBL] [Abstract][Full Text] [Related]
19. [When should we perform a bone scintigraphy in patients with new diagnosis of asymptomatic prostate cancer in order to detect bone metastasis?]. Márquez-López J; Gómez-Gómez E; Anaya-Henares F; Robles-Casilda R; Requena-Tapia MJ Arch Esp Urol; 2015 Mar; 68(2):135-41. PubMed ID: 25774820 [TBL] [Abstract][Full Text] [Related]
20. Prostate specific antigen level and Gleason score in predicting the stage of newly diagnosed prostate cancer. Spencer JA; Chng WJ; Hudson E; Boon AP; Whelan P Br J Radiol; 1998 Nov; 71(851):1130-5. PubMed ID: 10434906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]